Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01140646 · ClinicalTrials.gov registry record · Phase 2
Evaluation of SAMe for Hot Flashes
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT01140646: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT01140646 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01140646, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
RATIONALE: S-adenosyl-L-methionine may help relieve hot flashes in women based upon its ability to potentially modulate serotonin. PURPOSE: This phase II trial is studying the side effects and how well s-adenosyl-L-methionine works in treating hot flashes in women with a history of breast cancer or those who do not wish to take estrogen due to a perceived increased risk of breast cancer.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- DRUG S-adenosyl-L-methionine disulfate p-toluene-sulfonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01140646
The ClinicalTrials.gov registry entry for NCT01140646 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01140646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01140646 about?
NCT01140646 is a clinical study titled "Evaluation of SAMe for Hot Flashes". RATIONALE: S-adenosyl-L-methionine may help relieve hot flashes in women based upon its ability to potentially modulate serotonin. PURPOSE: This phase II trial is studying the side effects and how well s-adenosyl-L-methionine works in treating hot flashes in women with a history of breast cancer or...
What is the current status of trial NCT01140646?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2010-10. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01140646?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), S-adenosyl-L-methionine disulfate p-toluene-sulfonate (DRUG).
Who is sponsoring clinical trial NCT01140646?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.